BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang HH, Antonioli DA, Goldman H. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum Pathol. 1986;17:482-487. [PMID: 3699811 DOI: 10.1016/s0046-8177(86)80038-7] [Cited by in Crossref: 124] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Dunne B, Reynolds JV, Mulligan E, Kelly A, Griffin M. A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy. J Clin Pathol 2001;54:841-5. [PMID: 11684717 DOI: 10.1136/jcp.54.11.841] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sanchez-Diez A, Hernandez-Mejia R, Cueto-Espinar A. Study of the relation between diet and gastric cancer in a rural area of the Province of Leon, Spain. Eur J Epidemiol 1992;8:233-7. [PMID: 1644141 DOI: 10.1007/BF00144806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Nigro JJ, Hagen JA, DeMeester TR, DeMeester SR, Theisen J, Peters JH, Kiyabu M. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999;230:433-8; discussion 438-40. [PMID: 10493489 DOI: 10.1097/00000658-199909000-00015] [Cited by in Crossref: 137] [Cited by in F6Publishing: 129] [Article Influence: 6.2] [Reference Citation Analysis]
4 Ireland AP, Shibata DK, Chandrasoma P, Lord RV, Peters JH, DeMeester TR. Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg. 2000;231:179-187. [PMID: 10674608 DOI: 10.1097/00000658-200002000-00005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
5 Heidl G, Langhans P, Mellin W, Bünte H, Grundmann E. Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma. J Cancer Res Clin Oncol 1993;120:95-9. [PMID: 8270616 DOI: 10.1007/BF01200731] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
6 Fléjou JF, Gratio V, Muzeau F, Hamelin R. p53 abnormalities in adenocarcinoma of the gastric cardia and antrum. Mol Pathol 1999;52:263-8. [PMID: 10748875 DOI: 10.1136/mp.52.5.263] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
7 McKinney A, Sharp L, Macfarlane GJ, Muir CS. Oesophageal and gastric cancer in Scotland 1960-90. Br J Cancer. 1995;71:411-415. [PMID: 7841063 DOI: 10.1038/bjc.1995.84] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 2.1] [Reference Citation Analysis]
8 Stein HJ, Siewert JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia. 1993;8:276-288. [PMID: 8359051 DOI: 10.1007/bf01354551] [Cited by in Crossref: 73] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
9 Gleeson CM, Sloan JM, McManus DT, Maxwell P, Arthur K, McGuigan JA, Ritchie AJ, Russell SE. Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br J Cancer. 1998;77:277-286. [PMID: 9460999 DOI: 10.1038/bjc.1998.44] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 2.6] [Reference Citation Analysis]
10 Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH. Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control. 1995;6:532-538. [PMID: 8580302 DOI: 10.1007/bf00054162] [Cited by in Crossref: 128] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
11 Harrison JD, Morris DL, Hardcastle JD. Screening for gastric carcinoma in coal miners. Gut 1993;34:494-8. [PMID: 8491396 DOI: 10.1136/gut.34.4.494] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Jähne J, Osborne M, Meyer HJ, Weber K, Pichlmayr R. [Do immunologic markers facilitate differentiation between histologic types of stomach cancer?]. Langenbecks Arch Chir 1990;375:135-40. [PMID: 1693999 DOI: 10.1007/BF00206805] [Reference Citation Analysis]
13 Macfarlane GJ, Plesko I, Kramarova E, Obsitnikova A, Boyle P. Epidemiological features of gastric and oesophageal cancers in Slovakia. Br J Cancer 1994;70:177-9. [PMID: 8018533 DOI: 10.1038/bjc.1994.272] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
14 Wang LD, Zhou Q, Gao SS, Li YX, Yang WC. Measurements of cell proliferation in esophageal and gastric cardia epithelia of subjects in a high incidence area for esophageal cancer. World J Gastroenterol 1996; 2(2): 82-85 [DOI: 10.3748/wjg.v2.i2.82] [Cited by in CrossRef: 1] [Article Influence: 0.0] [Reference Citation Analysis]
15 Wayman J, Bennett MK, Raimes SA, Griffin SM. The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer. 2002;86:1223-1229. [PMID: 11953876 DOI: 10.1038/sj.bjc.6600252] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
16 Stewart JR, Hoff SJ, Johnson DH, Murray MJ, Butler DR, Elkins CC, Sharp KW, Merrill WH, Sawyers JL. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993;218:571-6; discussion 576-8. [PMID: 8215648 DOI: 10.1097/00000658-199310000-00017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 1.7] [Reference Citation Analysis]
17 Dolan K, Sutton R, Walker SJ, Morris AI, Campbell F, Williams EM. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer. 1999;80:834-842. [PMID: 10360663 DOI: 10.1038/sj.bjc.6690429] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 4.1] [Reference Citation Analysis]
18 Fléjou JF, Paraf F, Muzeau F, Fékété F, Hénin D, Jothy S, Potet F. Expression of c-erbB-2 oncogene product in Barrett’s adenocarcinoma: pathological and prognostic correlations. J Clin Pathol. 1994;47:23-26. [PMID: 7907608 DOI: 10.1136/jcp.47.1.23] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 3.0] [Reference Citation Analysis]
19 Tajima Y, Yamazaki K, Makino R, Nishino N, Masuda Y, Aoki S, Kato M, Morohara K, Kusano M. Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br J Cancer 2007;96:631-8. [PMID: 17262083 DOI: 10.1038/sj.bjc.6603583] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
20 Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SE. Allelotype analysis of adenocarcinoma of the gastric cardia. Br J Cancer. 1997;76:1455-1465. [PMID: 9400942 DOI: 10.1038/bjc.1997.578] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
21 Clark GW, Ireland AP, Peters JH, Chandrasoma P, DeMeester TR, Bremner CG. Short-segment Barrett's esophagus: A prevalent complication of gastroesophageal reflux disease with malignant potential. J Gastrointest Surg. 1997;1:113-122. [PMID: 9834337 DOI: 10.1016/S1091-255X(97)80098-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
22 D’Errico A, Barozzi C, Fiorentino M, Carella R, Di Simone M, Ferruzzi L, Mattioli S, Grigioni WF. Role and new perspectives of transforming growth factor-alpha (TGF-alpha) in adenocarcinoma of the gastro-oesophageal junction. Br J Cancer. 2000;82:865-870. [PMID: 10732760 DOI: 10.1054/bjoc.1999.1013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
23 Pera M. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg. 2003;27:999-1008; discussion 1006-1008. [PMID: 12917764 DOI: 10.1007/s00268-003-7052-2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
24 Castellà E, Ariza A, Fernández-Vasalo A, Roca X, Ojanguren I. Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma. J Clin Pathol. 1996;49:489-492. [PMID: 8763264 DOI: 10.1136/jcp.49.6.489] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
25 Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci. 1992;37:137-143. [PMID: 1728519 DOI: 10.1007/bf01308357] [Cited by in Crossref: 163] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
26 Boynton RF, Blount PL, Yin J, Brown VL, Huang Y, Tong Y, McDaniel T, Newkirk C, Resau JH, Raskind WH, Haggitt RC, Reid BJ, Meltzer SJ. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A 1992;89:3385-8. [PMID: 1565631 DOI: 10.1073/pnas.89.8.3385] [Cited by in Crossref: 129] [Cited by in F6Publishing: 139] [Article Influence: 4.4] [Reference Citation Analysis]
27 Kabat GC, Ng SK, Wynder EL. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control. 1993;4:123-132. [PMID: 8481491 DOI: 10.1007/bf00053153] [Cited by in Crossref: 188] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
28 Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520-530; discussion 530-531. [PMID: 11573045 DOI: 10.1097/00000658-200110000-00011] [Cited by in Crossref: 266] [Cited by in F6Publishing: 239] [Article Influence: 13.3] [Reference Citation Analysis]
29 Wang LD, Zheng S, Zheng ZY, Casson AG. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol 2003; 9(6): 1156-1164 [PMID: 12800215 DOI: 10.3748/wjg.v9.i6.1156] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
30 Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, Ritter MP, Mason RJ, Crookes P, Bremner CG. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 1997;226:522-530; discussion 530-532. [PMID: 9351720 DOI: 10.1097/00000658-199710000-00013] [Cited by in Crossref: 221] [Cited by in F6Publishing: 203] [Article Influence: 9.2] [Reference Citation Analysis]
31 Menges M. Gastric cancer: Where is the place for the surgeon, the oncologist and the endoscopist today? World J Gastrointest Oncol 2011; 3(1): 10-13 [PMID: 21267398 DOI: 10.4251/wjgo.v3.i1.10] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]